Menu Back to 9th-DIA-CMC-Forum-in-Japan

Overview

This program will be conducted in Japanese Language only.

Click Here to View the Program in Japanese

Program Committee

  • Tomoaki  Sakamoto, PhD
    Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
    National Institute of Health Sciences, Japan
  • Koki  Akazawa
    Koki Akazawa Inspector, Office of Manufacturing Quality for Drugs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Osamu  Hiruta, PhD
    Osamu Hiruta, PhD Manager, Quality assurance Dept., Reliability & Quality Assurance Division
    Meiji Seika Pharma Co., Ltd., Japan
  • Fusashi  Ishikawa, PhD, MSc
    Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
    Sumitomo Dainippon Pharma Co., Ltd., Japan
  • Motonori  Kidokoro, PhD
    Motonori Kidokoro, PhD Director, Regulatory Affairs CMC
    Daiichi Sankyo Pharma Development, United States
  • Yoshihiro  Matsuda, PhD
    Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Kazuji  Omori
    Kazuji Omori Inspector, Office of Manufacturing Quality for Drugs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Mitsuo  Sugiyama, PhD
    Mitsuo Sugiyama, PhD Deputy Director (CDMO), Business Strategy management Division
    CMIC Co., Ltd., Japan
  • Yutaka  Takahashi
    Yutaka Takahashi Senior Manager, Pharmaceutical Planning & Control
    Astellas Pharma Inc., Japan
  • Yukio  Hiyama, PhD
    Yukio Hiyama, PhD Visiting Researcher
    National Institute of Health Sciences, Japan
Load More

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download